longevityenergycognitive

NAD+

Nicotinamide Adenine Dinucleotide

Recharge your cellular energy and slow the aging clock

Moderate Preclinical / Emerging HumanLegal; available via telehealth prescription

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptides discussed may be research compounds not approved for human use. Always consult a qualified healthcare provider before starting any peptide protocol. Read our full disclaimer →

Quick Reference

Peptide ClassCoenzyme / Longevity Compound
Half-LifeVaries by form; IV effects last 4-6 hours, subcutaneous 12-24 hours
AdministrationIV infusion, Subcutaneous injection, Oral (NMN/NR precursors)
Typical Dosage250-500mg IV; 100-200mg subcutaneous
Cycle LengthOngoing; monthly IV or weekly subcutaneous
Evidence LevelModerate Preclinical / Emerging Human
Legal StatusLegal; available via telehealth prescription
Approximate Cost$150-400/session IV; $80-150/month subcutaneous

How NAD+ Works

Restores mitochondrial electron transport chain function and activates sirtuin longevity proteins

NAD+ fuels the mitochondrial electron transport chain, enabling ATP production. It also serves as a substrate for PARP enzymes (DNA repair) and sirtuins (epigenetic regulators of aging). Restoring NAD+ levels reactivates these pathways, improving cellular resilience and metabolic efficiency.

Evidence Base

Preclinical Evidence

Animal studies show lifespan extension and metabolic improvements with NAD+ precursor supplementation.

Human Evidence

Human trials demonstrate improved muscle function, cognitive performance, and metabolic markers.

Anecdotal Evidence

Users commonly report improved energy, mental clarity, and reduced fatigue within days of IV administration.

Key PubMed References:

Free Personalized Analysis

Is NAD+ right for your biology?

Take the 5-minute PeptidePilot quiz to get a personalized peptide match based on your goals, body, and lifestyle. Independent and vendor-neutral.

Safety Profile

Side Effects

Generally well-tolerated. IV administration may cause flushing, nausea, or headache during infusion. Subcutaneous injection site reactions are mild and transient.

Contraindications

Active cancer (NAD+ may theoretically support tumor cell metabolism). Consult a physician before use if you have a history of malignancy.

PeptidePilot Assessment

NAD+ is PeptidePilot's top recommendation for users prioritizing energy, cognitive performance, and longevity simultaneously. It is the single compound with the broadest evidence base across all three of these domains and represents exceptional value for users over 40.

📊 18% of PeptidePilot users with energy and longevity as co-primary concerns receive NAD+ as their top match

Frequently Asked Questions

Explore More Peptides